Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

5-Amino-1MQ vs Semaglutide

Comparison

5-Amino-1MQ and Semaglutide are two peptides people frequently compare. 5-Amino-1MQ is a compound people use for fat loss and metabolic support. It works by blocking an enzyme that controls how the body stores energy. Research is mostly in animals, with early interest in… Semaglutide is the active ingredient in Ozempic and Wegovy — prescribed for type 2 diabetes and weight loss. It works by curbing appetite and controlling blood sugar. Prescription only; also being…

5-Amino-1MQ Semaglutide
What it is 5-Amino-1MQ is a compound people use for fat loss and metabolic support. It works by blocking an enzyme that controls how the body stores energy. Research is mostly in animals, with early interest in… Semaglutide is the active ingredient in Ozempic and Wegovy — prescribed for type 2 diabetes and weight loss. It works by curbing appetite and controlling blood sugar. Prescription only; also being…
Primary uses
  • Urothelial bladder cancer (UBC) — NNMT inhibition to reduce tumor growth and enhance anti-PD-L1 immunotherapy response
  • Obesity / adiposity reduction (diet-induced obesity model)
  • Gut microbiome modulation in obesity
  • Anti-proliferative activity in cervical cancer (HeLa cells)
  • Type 2 diabetes mellitus — glycemic control
  • Obesity and overweight management — weight loss
  • Cardiovascular risk reduction — major adverse cardiovascular events (MACE)
  • Heart failure with preserved ejection fraction (HFpEF)
How it works It works by blocking an enzyme that controls how the body stores energy. Research is mostly in animals, with early interest in obesity, gut health, and some cancers. No FDA-approved use. It works by curbing appetite and controlling blood sugar. Prescription only; also being studied for heart, kidney, and liver conditions.
Common dose 50 mg, oral (capsule), once daily 0.25 mg, subcutaneous injection, once weekly
FDA status Not stated in reviewed literature — requires manual verification FDA approved under brand name Ozempic for treatment of type 2 diabetes and Wegovy for treatment of overweight or obesity; oral semaglutide (Rybelsus) approved for type 2 diabetes (PMID: 40966636,…
Evidence level Animal studies only Human RCT